Buzz Aldrin took this picture of Neil Armstrong in the cabin after the completion of the first EVA. This is the face of the first man to set foot on the Moon, just hours earlier, on July 20th, 1969.
Neil Armstrong was a quiet self-described nerdy engineer who became a global hero when as a steely-nerved pilot he made “one giant leap for mankind” with a small step on to the moon. The modest man who had people on Earth entranced and awed from almost a quarter million miles away has died. He was 82.
Human induced pluripotent stem cells (credit: UCSD)
A nationwide consortium of scientists at 20 institutions, led by a principal faculty member at the Harvard Stem Cell Institute (HSCI), has used stem cells to take a major step toward developing personalized medicine to treat Parkinson’s disease.
In part supported by the Harvard Miller Consortium for the Development of Nervous System Therapies, the team of scientists created induced pluripotent stem cells (iPS cells) from the skin cells of patients and at-risk individuals carrying genetic mutations implicated in Parkinson’s disease, and used those cells to derive neural cells, providing a platform for studying the disease in human cells outside of patients.
The researchers also report that although approximately 15 genetic mutations are linked to forms of Parkinson’s, many seem to affect themitochondria, the cell unit that produces most of its energy.
“This is the first comprehensive study of how human neuronal cells can be models of Parkinson’s, and how it might be treated,” said Ole Isacson, a leader of the study, an HSCI principal faculty member, and a Harvard Medical School professor of neurology, based at McLean Hospital’s Neuroregeneration Laboratory.
…
Human induced pluripotent stem cells (credit: UCSD)
A nationwide consortium of scientists at 20 institutions, led by a principal faculty member at the Harvard Stem Cell Institute (HSCI), has used stem cells to take a major step toward developing personalized medicine to treat Parkinson’s disease.
In part supported by the Harvard Miller Consortium for the Development of Nervous System Therapies, the team of scientists created induced pluripotent stem cells (iPS cells) from the skin cells of patients and at-risk individuals carrying genetic mutations implicated in Parkinson’s disease, and used those cells to derive neural cells, providing a platform for studying the disease in human cells outside of patients.
The researchers also report that although approximately 15 genetic mutations are linked to forms of Parkinson’s, many seem to affect themitochondria, the cell unit that produces most of its energy.
“This is the first comprehensive study of how human neuronal cells can be models of Parkinson’s, and how it might be treated,” said Ole Isacson, a leader of the study, an HSCI principal faculty member, and a Harvard Medical School professor of neurology, based at McLean Hospital’s Neuroregeneration Laboratory.
The Louvre to hand out 3DS systems as tour guides.
The Louvre museum in Paris - home to the Mona Lisa - is to replace it’s audio tour guides with Nintendo 3DS units.
The current audio guides are used by only 4 per cent of the museum’s 8.5 million annual visitors. With the 3DS, visitors will be able to locate themselves within The Louvre, select themed tours including specialised guides for children, and listen to “hundreds of commentaries in seven languages about the works on display,”
Nintendo has developed the content with guidance from The Louvre’s creators, and is also planning downloadable smartphone and tablet apps to enhance visitors’ experience.
Paul Higgins: Really - this is what we have come to?
You Are What You Tweet: 2011 In Review (Infographic)
Click through for full.
Downfall






